Increased MCP-1 levels in SMA-PME patients may also be used to distinguish them from patients with variations of SMA associated with other genetic deficiencies, for example SMN1-deficiency, where MCP-1 levels are inversely correlated with disease severity101. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.